These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36593701)

  • 1. Diabetes Mellitus and Energy Dysmetabolism in Alzheimer's Disease: Understanding the Relationships and Potential Therapeutic Targets.
    Onaolapo AY; Ojo FO; Adeleye OO; Falade J; Onaolapo OJ
    Curr Diabetes Rev; 2023; 19(8):e020123212333. PubMed ID: 36593701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of metabolism in neurodegenerative disorders.
    Procaccini C; Santopaolo M; Faicchia D; Colamatteo A; Formisano L; de Candia P; Galgani M; De Rosa V; Matarese G
    Metabolism; 2016 Sep; 65(9):1376-90. PubMed ID: 27506744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Resistance and Impaired Branched-Chain Amino Acid Metabolism in Alzheimer's Disease.
    Liu R; Zhang L; You H
    J Alzheimers Dis; 2023; 93(3):847-862. PubMed ID: 37125547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches.
    Bhattamisra SK; Shin LY; Saad HIBM; Rao V; Candasamy M; Pandey M; Choudhury H
    CNS Neurol Disord Drug Targets; 2020; 19(3):174-183. PubMed ID: 32418534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
    de la Monte SM
    Curr Alzheimer Res; 2012 Jan; 9(1):35-66. PubMed ID: 22329651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
    Duarte AI; Santos MS; Oliveira CR; Moreira PI
    Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
    Rivera EJ; Goldin A; Fulmer N; Tavares R; Wands JR; de la Monte SM
    J Alzheimers Dis; 2005 Dec; 8(3):247-68. PubMed ID: 16340083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.
    McLimans KE; Willette AA;
    J Alzheimers Dis; 2017; 56(1):403-413. PubMed ID: 27911319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
    Hamzé R; Delangre E; Tolu S; Moreau M; Janel N; Bailbé D; Movassat J
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Correlation between Diabetes Mellitus and Neurodegenerative Diseases.
    Schubert M
    Klin Monbl Augenheilkd; 2023 Feb; 240(2):130-135. PubMed ID: 36626931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones.
    Cardoso S; Moreira PI
    Int Rev Neurobiol; 2020; 155():37-64. PubMed ID: 32854858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease.
    Siddiqui N; Ali J; Parvez S; Najmi AK; Akhtar M
    Neurochem Res; 2023 Sep; 48(9):2714-2730. PubMed ID: 37079222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
    Lynn J; Park M; Ogunwale C; Acquaah-Mensah GK
    J Alzheimers Dis; 2022; 85(2):485-501. PubMed ID: 34842187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease.
    Kim B; Elzinga SE; Henn RE; McGinley LM; Feldman EL
    Neurobiol Dis; 2019 Dec; 132():104541. PubMed ID: 31349033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From obesity to Alzheimer's disease through insulin resistance.
    Terzo S; Amato A; Mulè F
    J Diabetes Complications; 2021 Nov; 35(11):108026. PubMed ID: 34454830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.